Labeler
Accord Healthcare Inc. NDC Codes
Accord Healthcare Inc. lists 227 finished drug products in the FDA NDC Directory under NDC labeler code 16729.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Levothyroxine sodium, Lenalidomide, lurasidone hydrochloride, Hydroxychloroquine Sulfate, Glycopyrrolate, Tadalafil, Vilazodone Hydrochloride, Pemetrexed, Atropine Sulfate, Furosemide, Methylphenidate Hydrochloride, Olmesartan Medoxomil And Hydrochlorothiazide, Diltiazem Hydrochloride, Dofetilide, Cinacalcet
- Active ingredients
- Levothyroxine sodium, Lenalidomide, Lurasidone hydrochloride, Hydroxychloroquine sulfate, Glycopyrrolate, Tadalafil, Vilazodone hydrochloride, Pemetrexed disodium hemipentahydrate, Atropine sulfate, Furosemide, Methylphenidate hydrochloride, Olmesartan medoxomil
- NDC labeler codes
- 16729
- Strengths (from the 100 most recently listed products)
- Glycopyrrolate .2 mg/mL; Furosemide 10 mg/mL; Hydrochlorothiazide 12.5 mg/1; Olmesartan medoxomil 40 mg/1; Sugammadex sodium 200 mg/2mL; Sugammadex sodium 500 mg/5mL; Lenalidomide 2.5 mg/1; Lenalidomide 25 mg/1; Lenalidomide 15 mg/1; Lenalidomide 5 mg/1; Lenalidomide 20 mg/1; Lenalidomide 10 mg/1; Clomiphene citrate 50 mg/1; Alcohol 1 mL/mL; Teriflunomide 7 mg/1; Teriflunomide 14 mg/1; Regadenoson .08 mg/mL; Lurasidone hydrochloride 20 mg/1; Lurasidone hydrochloride 40 mg/1; Lurasidone hydrochloride 60 mg/1
- Dosage forms
- Tablet, Tablet, Film coated, Injection, Capsule, Injection, Powder, Lyophilized, For solution, Injection, Solution, Tablet, Extended release, Capsule, Extended release, Capsule, Delayed release, Ointment, Cream
- Routes
- Oral, Intravenous, Intramuscular, Topical, Subcutaneous, Sublingual, Percutaneous, Endotracheal, Intramedullary
- Drug classes (FDA established)
- l-Thyroxine, Atypical Antipsychotic, Anticholinergic, Cholinergic Muscarinic Antagonist, Thalidomide Analog, Folate Analog Metabolic Inhibitor, Antimalarial, Antirheumatic Agent, Phosphodiesterase 5 Inhibitor, Alkylating Drug, Loop Diuretic, Central Nervous System Stimulant, Angiotensin 2 Receptor Blocker, Thiazide Diuretic, Calcium Channel Blocker, Antiarrhythmic, Calcium-sensing Receptor Agonist, Pyrimidine Synthesis Inhibitor, Pyridone, Nucleoside Metabolic Inhibitor, Anti-coagulant, Direct Thrombin Inhibitor, Opioid Antagonist, Partial Opioid Agonist, Lipopeptide Antibacterial, Calcineurin Inhibitor Immunosuppressant, Aminoketone, P2Y12 Platelet Inhibitor, Estrogen Agonist/Antagonist, Pharmacologic Cardiac Stress Test Agent, Sphingosine 1-phosphate Receptor Modulator, Carbonic Anhydrase Inhibitor, Estrogen Receptor Antagonist, Topoisomerase Inhibitor, Dietary Cholesterol Absorption Inhibitor, Serotonin Reuptake Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 137 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| sugammadex | Sugammadex sodium 200 mg/2mL | Injection, SolutionIntravenous | 16729-726 | 16729-0726-03 | — |
| sugammadex | Sugammadex sodium 500 mg/5mL | Injection, SolutionIntravenous | 16729-727 | 16729-0727-03 | — |
| Lenalidomide | Lenalidomide 2.5 mg/1 | CapsuleOral | 16729-692 | 16729-0692-09 | — |
| Lenalidomide | Lenalidomide 25 mg/1 | CapsuleOral | 16729-697 | 16729-0697-06 | — |
| Lenalidomide | Lenalidomide 15 mg/1 | CapsuleOral | 16729-695 | 16729-0695-06 | — |
| Lenalidomide | Lenalidomide 5 mg/1 | CapsuleOral | 16729-693 | 16729-0693-09 | — |
| Lenalidomide | Lenalidomide 20 mg/1 | CapsuleOral | 16729-696 | 16729-0696-06 | — |
| Lenalidomide | Lenalidomide 10 mg/1 | CapsuleOral | 16729-694 | 16729-0694-09 | — |
| Clomiphene Citrate | Clomiphene citrate 50 mg/1 | TabletOral | 16729-723 | 16729-0723-51 | — |
| Dehydrated Alcoholalcohol | Alcohol 1 mL/mL | Injection, SolutionPercutaneous | 16729-710 | 16729-0710-4516729-0710-53 | — |
| Teriflunomide | Teriflunomide 7 mg/1 | Tablet, Film coatedOral | 16729-399 | 16729-0399-10 | — |
| Teriflunomide | Teriflunomide 14 mg/1 | Tablet, Film coatedOral | 16729-400 | 16729-0400-10 | — |
| Regadenoson | Regadenoson .08 mg/mL | Injection, SolutionIntravenous | 16729-477 | 16729-0477-31 | — |
| lurasidone hydrochloride | Lurasidone hydrochloride 20 mg/1 | Tablet, Film coatedOral | 16729-346 | 16729-0346-10 | — |
| lurasidone hydrochloride | Lurasidone hydrochloride 40 mg/1 | Tablet, Film coatedOral | 16729-347 | 16729-0347-10 | — |
| lurasidone hydrochloride | Lurasidone hydrochloride 60 mg/1 | Tablet, Film coatedOral | 16729-348 | 16729-0348-10 | — |
| lurasidone hydrochloride | Lurasidone hydrochloride 80 mg/1 | Tablet, Film coatedOral | 16729-349 | 16729-0349-10 | — |
| lurasidone hydrochloride | Lurasidone hydrochloride 120 mg/1 | Tablet, Film coatedOral | 16729-350 | 16729-0350-10 | — |
| bendamustine hydrochloride | Bendamustine hydrochloride 25 mg/5mL | Injection, Powder, Lyophilized, For solutionIntravenous | 16729-250 | 16729-0250-03 | — |
| bendamustine hydrochloride | Bendamustine hydrochloride 100 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | 16729-251 | 16729-0251-05 | — |
| Fingolimod Hydrochloride | Fingolimod hydrochloride .5 mg/1 | CapsuleOral | 16729-342 | 16729-0342-10 | — |
| Vilazodone Hydrochloride | Vilazodone hydrochloride 10 mg/1 | TabletOral | 16729-352 | 16729-0352-10 | — |
| Vilazodone Hydrochloride | Vilazodone hydrochloride 20 mg/1 | TabletOral | 16729-353 | 16729-0353-10 | — |
| Vilazodone Hydrochloride | Vilazodone hydrochloride 40 mg/1 | TabletOral | 16729-354 | 16729-0354-10 | — |
| Pirfenidone | Pirfenidone 267 mg/1 | Tablet, Film coatedOral | 16729-467 | 16729-0467-85 | — |
| Pirfenidone | Pirfenidone 801 mg/1 | Tablet, Film coatedOral | 16729-468 | 16729-0468-15 | — |
| Pemetrexed | Pemetrexed disodium hemipentahydrate 100 mg/4mL | Injection, Powder, Lyophilized, For solutionIntravenous | 16729-229 | 16729-0229-03 | — |
| Pemetrexed | Pemetrexed disodium hemipentahydrate 500 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | 16729-230 | 16729-0230-11 | — |
| Pemetrexed | Pemetrexed disodium hemipentahydrate 1 g/40mL | Injection, Powder, Lyophilized, For solutionIntravenous | 16729-244 | 16729-0244-38 | — |
| acetazolamide | Acetazolamide 500 mg/1 | Capsule, Extended releaseOral | 16729-331 | 16729-0331-01 | — |
| Fluorouracil | Fluorouracil 50 mg/g | CreamTopical | 16729-542 | 16729-0542-35 | — |
| Argatroban | Argatroban 1 mg/mL | InjectionIntravenous | 16729-430 | 16729-0430-1116729-0430-43 | — |
| Hydroxychloroquine Sulfate | Hydroxychloroquine sulfate 100 mg/1 | TabletOral | 16729-561 | 16729-0561-01 | — |
| Hydroxychloroquine Sulfate | Hydroxychloroquine sulfate 300 mg/1 | TabletOral | 16729-562 | 16729-0562-01 | — |
| Hydroxychloroquine Sulfate | Hydroxychloroquine sulfate 400 mg/1 | TabletOral | 16729-563 | 16729-0563-01 | — |
| Atropine Sulfate | Atropine sulfate .05 mg/mL | InjectionIntravenous | 16729-483 | 16729-0483-0316729-0483-31 | — |
| Atropine Sulfate | Atropine sulfate .1 mg/mL | InjectionIntravenous | 16729-484 | 16729-0484-0316729-0484-3116729-0484-45+1 more | — |
| Furosemide | Furosemide 10 mg/mL | InjectionIntramuscular, Intravenous | 16729-500 | 16729-0500-08 | — |
| Furosemide | Furosemide 10 mg/mL | InjectionIntramuscular, Intravenous | 16729-501 | 16729-0501-43 | — |
| Furosemide | Furosemide 10 mg/mL | InjectionIntramuscular, Intravenous | 16729-502 | 16729-0502-43 | — |
| Atropine Sulfate | Atropine sulfate .4 mg/mL | Injection, SolutionEndotracheal, Intramedullary, Intramuscular, Intravenous, Subcutaneous | 16729-512 | 16729-0512-43 | — |
| Dimethyl Fumarate | Dimethyl fumarate 120 mg/1 | Capsule, Delayed releaseOral | 16729-416 | 16729-0416-04 | — |
| Fulvestrant | Fulvestrant 250 mg/5mL | InjectionIntramuscular | 16729-436 | 16729-0436-30 | — |
| Dimethyl Fumarate | Dimethyl fumarate 240 mg/1 | Capsule, Delayed releaseOral | 16729-417 | 16729-0417-1216729-0417-59 | — |
| Methylphenidate Hydrochloride | Methylphenidate hydrochloride 5 mg/1 | TabletOral | 16729-478 | 16729-0478-01 | — |
| Glycopyrrolate | Glycopyrrolate .2 mg/mL | InjectionIntramuscular, Intravenous | 16729-471 | 16729-0471-08 | — |
| Methylphenidate Hydrochloride | Methylphenidate hydrochloride 10 mg/1 | TabletOral | 16729-479 | 16729-0479-01 | — |
| Methylphenidate Hydrochloride | Methylphenidate hydrochloride 20 mg/1 | TabletOral | 16729-480 | 16729-0480-01 | — |
| Levothyroxine sodium | Levothyroxine sodium 25 ug/1 | TabletOral | 16729-447 | 16729-0447-1516729-0447-17 | — |
| Levothyroxine sodium | Levothyroxine sodium 100 ug/1 | TabletOral | 16729-451 | 16729-0451-1516729-0451-17 | — |
Accord Healthcare Inc.: common questions
- What is Accord Healthcare Inc.'s NDC labeler code?
- 16729. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Accord Healthcare Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.